Zephyr AI Appoints Dr. Lisa Eli as Chief Scientific Officer [Yahoo! Finance]
Puma Biotechnology Inc (PBYI)
Last puma biotechnology inc earnings: 2/20 04:07 pm
Check Earnings Report
US:NYSE Investor Relations:
pumabiotechnology.com/ir.html
Company Research
Source: Yahoo! Finance
intelligence to accelerate drug development, today announced that it has appointed Lisa Eli, PhD, as its Chief Scientific Officer. Eli brings over 20 years of experience in translational medicine and precision oncology, with deep expertise in advancing biomarker-driven clinical development. She has led integrated biomarker and diagnostic strategies across Phase 1-3 clinical trials, enabling patient selection, informing combination approaches, and supporting regulatory approvals and guideline inclusions in solid tumors. At Zephyr AI, Dr. Eli will leverage this experience to accelerate AI-powered, biomarker-driven diagnostic and clinical development of targeted therapies. "I am thrilled to join Zephyr AI and support the company's groundbreaking work in oncology discovery and drug development," said Eli. "The power of AI combined with deeply profiled real-world data offers an immense opportunity to accelerate clinical development and bring biomarker-informed, precise therapies to point
Show less
Read more
Impact Snapshot
Event Time:
PBYI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBYI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBYI alerts
High impacting Puma Biotechnology Inc news events
Weekly update
A roundup of the hottest topics
PBYI
News
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why [Yahoo! Finance]Yahoo! Finance
- Puma Biotechnology (PBYI) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=PBYI&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold"MarketBeat
- Puma Biotechnology Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Puma Biotechnology, Inc. (PBYI) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
PBYI
Earnings
- 2/26/26 - Beat
PBYI
Sec Filings
- 4/7/26 - Form PRE
- 3/27/26 - Form SCHEDULE
- 2/26/26 - Form 10-K
- PBYI's page on the SEC website